Global GLP-1 Weight Loss Drug Market Growth 2026-2032
The global GLP-1 Weight Loss Drug market size is predicted to grow from US$ million in 2025 to US$ million in 2032; it is expected to grow at a CAGR of %from 2026 to 2032.
GLP-1 (Glucagon-Like Peptide-1) weight loss drugs are a class of drugs used to treat obesity and control weight. GLP-1 is a naturally occurring insulin-releasing hormone produced by cells in the small intestine after food ingestion and has multiple physiological effects, including stimulating insulin secretion and inhibiting gastric emptying, thereby slowing the passage of food through the gastrointestinal tract. GLP-1 weight loss drugs simulate the biological activity of GLP-1 and trigger a series of physiological reactions, which help reduce appetite, increase satiety, and reduce calorie intake, thereby helping people lose weight. This class of drugs is often used to treat obesity, especially in obese patients who are at risk for diabetes.
United States market for GLP-1 Weight Loss Drug is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
China market for GLP-1 Weight Loss Drug is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Europe market for GLP-1 Weight Loss Drug is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Global key GLP-1 Weight Loss Drug players cover Novo Nordisk, AstraZeneca, Eli Lilly, Sanofi, BENEMAE, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.
LP Information, Inc. (LPI) ' newest research report, the “GLP-1 Weight Loss Drug Industry Forecast” looks at past sales and reviews total world GLP-1 Weight Loss Drug sales in 2025, providing a comprehensive analysis by region and market sector of projected GLP-1 Weight Loss Drug sales for 2026 through 2032. With GLP-1 Weight Loss Drug sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world GLP-1 Weight Loss Drug industry.
This Insight Report provides a comprehensive analysis of the global GLP-1 Weight Loss Drug landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on GLP-1 Weight Loss Drug portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global GLP-1 Weight Loss Drug market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for GLP-1 Weight Loss Drug and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global GLP-1 Weight Loss Drug.
This report presents a comprehensive overview, market shares, and growth opportunities of GLP-1 Weight Loss Drug market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
GLP-1 (Glucagon-Like Peptide-1) weight loss drugs are a class of drugs used to treat obesity and control weight. GLP-1 is a naturally occurring insulin-releasing hormone produced by cells in the small intestine after food ingestion and has multiple physiological effects, including stimulating insulin secretion and inhibiting gastric emptying, thereby slowing the passage of food through the gastrointestinal tract. GLP-1 weight loss drugs simulate the biological activity of GLP-1 and trigger a series of physiological reactions, which help reduce appetite, increase satiety, and reduce calorie intake, thereby helping people lose weight. This class of drugs is often used to treat obesity, especially in obese patients who are at risk for diabetes.
United States market for GLP-1 Weight Loss Drug is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
China market for GLP-1 Weight Loss Drug is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Europe market for GLP-1 Weight Loss Drug is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Global key GLP-1 Weight Loss Drug players cover Novo Nordisk, AstraZeneca, Eli Lilly, Sanofi, BENEMAE, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.
LP Information, Inc. (LPI) ' newest research report, the “GLP-1 Weight Loss Drug Industry Forecast” looks at past sales and reviews total world GLP-1 Weight Loss Drug sales in 2025, providing a comprehensive analysis by region and market sector of projected GLP-1 Weight Loss Drug sales for 2026 through 2032. With GLP-1 Weight Loss Drug sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world GLP-1 Weight Loss Drug industry.
This Insight Report provides a comprehensive analysis of the global GLP-1 Weight Loss Drug landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on GLP-1 Weight Loss Drug portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global GLP-1 Weight Loss Drug market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for GLP-1 Weight Loss Drug and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global GLP-1 Weight Loss Drug.
This report presents a comprehensive overview, market shares, and growth opportunities of GLP-1 Weight Loss Drug market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- Injection
- Oral
- Online Pharmacy
- Offline Pharmacy
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Novo Nordisk
- AstraZeneca
- Eli Lilly
- Sanofi
- BENEMAE
- HANSOH PHARMLA
- CHIATAI TIANQING
- Tonghua Dongbao Pharmaceutical
- Huadong Medicine
- What is the 10-year outlook for the global GLP-1 Weight Loss Drug market?
- What factors are driving GLP-1 Weight Loss Drug market growth, globally and by region?
- Which technologies are poised for the fastest growth by market and region?
- How do GLP-1 Weight Loss Drug market opportunities vary by end market size?
- How does GLP-1 Weight Loss Drug break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global GLP-1 Weight Loss Drug Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for GLP-1 Weight Loss Drug by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for GLP-1 Weight Loss Drug by Country/Region, 2021, 2025 & 2032
2.2 GLP-1 Weight Loss Drug Segment by Type
2.2.1 Injection
2.2.2 Oral
2.2.3 GLP-1 Weight Loss Drug Sales by Type
2.2.3.1 Global GLP-1 Weight Loss Drug Sales Market Share by Type (2021-2026)
2.2.3.2 Global GLP-1 Weight Loss Drug Revenue and Market Share by Type (2021-2026)
2.2.3.3 Global GLP-1 Weight Loss Drug Sale Price by Type (2021-2026)
2.3 GLP-1 Weight Loss Drug Segment by Application
2.3.1 Online Pharmacy
2.3.2 Offline Pharmacy
2.3.3 GLP-1 Weight Loss Drug Sales by Application
2.3.3.1 Global GLP-1 Weight Loss Drug Sale Market Share by Application (2021-2026)
2.3.3.2 Global GLP-1 Weight Loss Drug Revenue and Market Share by Application (2021-2026)
2.3.3.3 Global GLP-1 Weight Loss Drug Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global GLP-1 Weight Loss Drug Breakdown Data by Company
3.1.1 Global GLP-1 Weight Loss Drug Annual Sales by Company (2021-2026)
3.1.2 Global GLP-1 Weight Loss Drug Sales Market Share by Company (2021-2026)
3.2 Global GLP-1 Weight Loss Drug Annual Revenue by Company (2021-2026)
3.2.1 Global GLP-1 Weight Loss Drug Revenue by Company (2021-2026)
3.2.2 Global GLP-1 Weight Loss Drug Revenue Market Share by Company (2021-2026)
3.3 Global GLP-1 Weight Loss Drug Sale Price by Company
3.4 Key Manufacturers GLP-1 Weight Loss Drug Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers GLP-1 Weight Loss Drug Product Location Distribution
3.4.2 Players GLP-1 Weight Loss Drug Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR GLP-1 WEIGHT LOSS DRUG BY GEOGRAPHIC REGION
4.1 World Historic GLP-1 Weight Loss Drug Market Size by Geographic Region (2021-2026)
4.1.1 Global GLP-1 Weight Loss Drug Annual Sales by Geographic Region (2021-2026)
4.1.2 Global GLP-1 Weight Loss Drug Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic GLP-1 Weight Loss Drug Market Size by Country/Region (2021-2026)
4.2.1 Global GLP-1 Weight Loss Drug Annual Sales by Country/Region (2021-2026)
4.2.2 Global GLP-1 Weight Loss Drug Annual Revenue by Country/Region (2021-2026)
4.3 Americas GLP-1 Weight Loss Drug Sales Growth
4.4 APAC GLP-1 Weight Loss Drug Sales Growth
4.5 Europe GLP-1 Weight Loss Drug Sales Growth
4.6 Middle East & Africa GLP-1 Weight Loss Drug Sales Growth
5 AMERICAS
5.1 Americas GLP-1 Weight Loss Drug Sales by Country
5.1.1 Americas GLP-1 Weight Loss Drug Sales by Country (2021-2026)
5.1.2 Americas GLP-1 Weight Loss Drug Revenue by Country (2021-2026)
5.2 Americas GLP-1 Weight Loss Drug Sales by Type (2021-2026)
5.3 Americas GLP-1 Weight Loss Drug Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC GLP-1 Weight Loss Drug Sales by Region
6.1.1 APAC GLP-1 Weight Loss Drug Sales by Region (2021-2026)
6.1.2 APAC GLP-1 Weight Loss Drug Revenue by Region (2021-2026)
6.2 APAC GLP-1 Weight Loss Drug Sales by Type (2021-2026)
6.3 APAC GLP-1 Weight Loss Drug Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe GLP-1 Weight Loss Drug by Country
7.1.1 Europe GLP-1 Weight Loss Drug Sales by Country (2021-2026)
7.1.2 Europe GLP-1 Weight Loss Drug Revenue by Country (2021-2026)
7.2 Europe GLP-1 Weight Loss Drug Sales by Type (2021-2026)
7.3 Europe GLP-1 Weight Loss Drug Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa GLP-1 Weight Loss Drug by Country
8.1.1 Middle East & Africa GLP-1 Weight Loss Drug Sales by Country (2021-2026)
8.1.2 Middle East & Africa GLP-1 Weight Loss Drug Revenue by Country (2021-2026)
8.2 Middle East & Africa GLP-1 Weight Loss Drug Sales by Type (2021-2026)
8.3 Middle East & Africa GLP-1 Weight Loss Drug Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of GLP-1 Weight Loss Drug
10.3 Manufacturing Process Analysis of GLP-1 Weight Loss Drug
10.4 Industry Chain Structure of GLP-1 Weight Loss Drug
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 GLP-1 Weight Loss Drug Distributors
11.3 GLP-1 Weight Loss Drug Customer
12 WORLD FORECAST REVIEW FOR GLP-1 WEIGHT LOSS DRUG BY GEOGRAPHIC REGION
12.1 Global GLP-1 Weight Loss Drug Market Size Forecast by Region
12.1.1 Global GLP-1 Weight Loss Drug Forecast by Region (2027-2032)
12.1.2 Global GLP-1 Weight Loss Drug Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global GLP-1 Weight Loss Drug Forecast by Type (2027-2032)
12.7 Global GLP-1 Weight Loss Drug Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Novo Nordisk
13.1.1 Novo Nordisk Company Information
13.1.2 Novo Nordisk GLP-1 Weight Loss Drug Product Portfolios and Specifications
13.1.3 Novo Nordisk GLP-1 Weight Loss Drug Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Novo Nordisk Main Business Overview
13.1.5 Novo Nordisk Latest Developments
13.2 AstraZeneca
13.2.1 AstraZeneca Company Information
13.2.2 AstraZeneca GLP-1 Weight Loss Drug Product Portfolios and Specifications
13.2.3 AstraZeneca GLP-1 Weight Loss Drug Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 AstraZeneca Main Business Overview
13.2.5 AstraZeneca Latest Developments
13.3 Eli Lilly
13.3.1 Eli Lilly Company Information
13.3.2 Eli Lilly GLP-1 Weight Loss Drug Product Portfolios and Specifications
13.3.3 Eli Lilly GLP-1 Weight Loss Drug Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 Eli Lilly Main Business Overview
13.3.5 Eli Lilly Latest Developments
13.4 Sanofi
13.4.1 Sanofi Company Information
13.4.2 Sanofi GLP-1 Weight Loss Drug Product Portfolios and Specifications
13.4.3 Sanofi GLP-1 Weight Loss Drug Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 Sanofi Main Business Overview
13.4.5 Sanofi Latest Developments
13.5 BENEMAE
13.5.1 BENEMAE Company Information
13.5.2 BENEMAE GLP-1 Weight Loss Drug Product Portfolios and Specifications
13.5.3 BENEMAE GLP-1 Weight Loss Drug Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 BENEMAE Main Business Overview
13.5.5 BENEMAE Latest Developments
13.6 HANSOH PHARMLA
13.6.1 HANSOH PHARMLA Company Information
13.6.2 HANSOH PHARMLA GLP-1 Weight Loss Drug Product Portfolios and Specifications
13.6.3 HANSOH PHARMLA GLP-1 Weight Loss Drug Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 HANSOH PHARMLA Main Business Overview
13.6.5 HANSOH PHARMLA Latest Developments
13.7 CHIATAI TIANQING
13.7.1 CHIATAI TIANQING Company Information
13.7.2 CHIATAI TIANQING GLP-1 Weight Loss Drug Product Portfolios and Specifications
13.7.3 CHIATAI TIANQING GLP-1 Weight Loss Drug Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 CHIATAI TIANQING Main Business Overview
13.7.5 CHIATAI TIANQING Latest Developments
13.8 Tonghua Dongbao Pharmaceutical
13.8.1 Tonghua Dongbao Pharmaceutical Company Information
13.8.2 Tonghua Dongbao Pharmaceutical GLP-1 Weight Loss Drug Product Portfolios and Specifications
13.8.3 Tonghua Dongbao Pharmaceutical GLP-1 Weight Loss Drug Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 Tonghua Dongbao Pharmaceutical Main Business Overview
13.8.5 Tonghua Dongbao Pharmaceutical Latest Developments
13.9 Huadong Medicine
13.9.1 Huadong Medicine Company Information
13.9.2 Huadong Medicine GLP-1 Weight Loss Drug Product Portfolios and Specifications
13.9.3 Huadong Medicine GLP-1 Weight Loss Drug Sales, Revenue, Price and Gross Margin (2021-2026)
13.9.4 Huadong Medicine Main Business Overview
13.9.5 Huadong Medicine Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global GLP-1 Weight Loss Drug Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for GLP-1 Weight Loss Drug by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for GLP-1 Weight Loss Drug by Country/Region, 2021, 2025 & 2032
2.2 GLP-1 Weight Loss Drug Segment by Type
2.2.1 Injection
2.2.2 Oral
2.2.3 GLP-1 Weight Loss Drug Sales by Type
2.2.3.1 Global GLP-1 Weight Loss Drug Sales Market Share by Type (2021-2026)
2.2.3.2 Global GLP-1 Weight Loss Drug Revenue and Market Share by Type (2021-2026)
2.2.3.3 Global GLP-1 Weight Loss Drug Sale Price by Type (2021-2026)
2.3 GLP-1 Weight Loss Drug Segment by Application
2.3.1 Online Pharmacy
2.3.2 Offline Pharmacy
2.3.3 GLP-1 Weight Loss Drug Sales by Application
2.3.3.1 Global GLP-1 Weight Loss Drug Sale Market Share by Application (2021-2026)
2.3.3.2 Global GLP-1 Weight Loss Drug Revenue and Market Share by Application (2021-2026)
2.3.3.3 Global GLP-1 Weight Loss Drug Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global GLP-1 Weight Loss Drug Breakdown Data by Company
3.1.1 Global GLP-1 Weight Loss Drug Annual Sales by Company (2021-2026)
3.1.2 Global GLP-1 Weight Loss Drug Sales Market Share by Company (2021-2026)
3.2 Global GLP-1 Weight Loss Drug Annual Revenue by Company (2021-2026)
3.2.1 Global GLP-1 Weight Loss Drug Revenue by Company (2021-2026)
3.2.2 Global GLP-1 Weight Loss Drug Revenue Market Share by Company (2021-2026)
3.3 Global GLP-1 Weight Loss Drug Sale Price by Company
3.4 Key Manufacturers GLP-1 Weight Loss Drug Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers GLP-1 Weight Loss Drug Product Location Distribution
3.4.2 Players GLP-1 Weight Loss Drug Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR GLP-1 WEIGHT LOSS DRUG BY GEOGRAPHIC REGION
4.1 World Historic GLP-1 Weight Loss Drug Market Size by Geographic Region (2021-2026)
4.1.1 Global GLP-1 Weight Loss Drug Annual Sales by Geographic Region (2021-2026)
4.1.2 Global GLP-1 Weight Loss Drug Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic GLP-1 Weight Loss Drug Market Size by Country/Region (2021-2026)
4.2.1 Global GLP-1 Weight Loss Drug Annual Sales by Country/Region (2021-2026)
4.2.2 Global GLP-1 Weight Loss Drug Annual Revenue by Country/Region (2021-2026)
4.3 Americas GLP-1 Weight Loss Drug Sales Growth
4.4 APAC GLP-1 Weight Loss Drug Sales Growth
4.5 Europe GLP-1 Weight Loss Drug Sales Growth
4.6 Middle East & Africa GLP-1 Weight Loss Drug Sales Growth
5 AMERICAS
5.1 Americas GLP-1 Weight Loss Drug Sales by Country
5.1.1 Americas GLP-1 Weight Loss Drug Sales by Country (2021-2026)
5.1.2 Americas GLP-1 Weight Loss Drug Revenue by Country (2021-2026)
5.2 Americas GLP-1 Weight Loss Drug Sales by Type (2021-2026)
5.3 Americas GLP-1 Weight Loss Drug Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC GLP-1 Weight Loss Drug Sales by Region
6.1.1 APAC GLP-1 Weight Loss Drug Sales by Region (2021-2026)
6.1.2 APAC GLP-1 Weight Loss Drug Revenue by Region (2021-2026)
6.2 APAC GLP-1 Weight Loss Drug Sales by Type (2021-2026)
6.3 APAC GLP-1 Weight Loss Drug Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe GLP-1 Weight Loss Drug by Country
7.1.1 Europe GLP-1 Weight Loss Drug Sales by Country (2021-2026)
7.1.2 Europe GLP-1 Weight Loss Drug Revenue by Country (2021-2026)
7.2 Europe GLP-1 Weight Loss Drug Sales by Type (2021-2026)
7.3 Europe GLP-1 Weight Loss Drug Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa GLP-1 Weight Loss Drug by Country
8.1.1 Middle East & Africa GLP-1 Weight Loss Drug Sales by Country (2021-2026)
8.1.2 Middle East & Africa GLP-1 Weight Loss Drug Revenue by Country (2021-2026)
8.2 Middle East & Africa GLP-1 Weight Loss Drug Sales by Type (2021-2026)
8.3 Middle East & Africa GLP-1 Weight Loss Drug Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of GLP-1 Weight Loss Drug
10.3 Manufacturing Process Analysis of GLP-1 Weight Loss Drug
10.4 Industry Chain Structure of GLP-1 Weight Loss Drug
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 GLP-1 Weight Loss Drug Distributors
11.3 GLP-1 Weight Loss Drug Customer
12 WORLD FORECAST REVIEW FOR GLP-1 WEIGHT LOSS DRUG BY GEOGRAPHIC REGION
12.1 Global GLP-1 Weight Loss Drug Market Size Forecast by Region
12.1.1 Global GLP-1 Weight Loss Drug Forecast by Region (2027-2032)
12.1.2 Global GLP-1 Weight Loss Drug Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global GLP-1 Weight Loss Drug Forecast by Type (2027-2032)
12.7 Global GLP-1 Weight Loss Drug Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Novo Nordisk
13.1.1 Novo Nordisk Company Information
13.1.2 Novo Nordisk GLP-1 Weight Loss Drug Product Portfolios and Specifications
13.1.3 Novo Nordisk GLP-1 Weight Loss Drug Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Novo Nordisk Main Business Overview
13.1.5 Novo Nordisk Latest Developments
13.2 AstraZeneca
13.2.1 AstraZeneca Company Information
13.2.2 AstraZeneca GLP-1 Weight Loss Drug Product Portfolios and Specifications
13.2.3 AstraZeneca GLP-1 Weight Loss Drug Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 AstraZeneca Main Business Overview
13.2.5 AstraZeneca Latest Developments
13.3 Eli Lilly
13.3.1 Eli Lilly Company Information
13.3.2 Eli Lilly GLP-1 Weight Loss Drug Product Portfolios and Specifications
13.3.3 Eli Lilly GLP-1 Weight Loss Drug Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 Eli Lilly Main Business Overview
13.3.5 Eli Lilly Latest Developments
13.4 Sanofi
13.4.1 Sanofi Company Information
13.4.2 Sanofi GLP-1 Weight Loss Drug Product Portfolios and Specifications
13.4.3 Sanofi GLP-1 Weight Loss Drug Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 Sanofi Main Business Overview
13.4.5 Sanofi Latest Developments
13.5 BENEMAE
13.5.1 BENEMAE Company Information
13.5.2 BENEMAE GLP-1 Weight Loss Drug Product Portfolios and Specifications
13.5.3 BENEMAE GLP-1 Weight Loss Drug Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 BENEMAE Main Business Overview
13.5.5 BENEMAE Latest Developments
13.6 HANSOH PHARMLA
13.6.1 HANSOH PHARMLA Company Information
13.6.2 HANSOH PHARMLA GLP-1 Weight Loss Drug Product Portfolios and Specifications
13.6.3 HANSOH PHARMLA GLP-1 Weight Loss Drug Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 HANSOH PHARMLA Main Business Overview
13.6.5 HANSOH PHARMLA Latest Developments
13.7 CHIATAI TIANQING
13.7.1 CHIATAI TIANQING Company Information
13.7.2 CHIATAI TIANQING GLP-1 Weight Loss Drug Product Portfolios and Specifications
13.7.3 CHIATAI TIANQING GLP-1 Weight Loss Drug Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 CHIATAI TIANQING Main Business Overview
13.7.5 CHIATAI TIANQING Latest Developments
13.8 Tonghua Dongbao Pharmaceutical
13.8.1 Tonghua Dongbao Pharmaceutical Company Information
13.8.2 Tonghua Dongbao Pharmaceutical GLP-1 Weight Loss Drug Product Portfolios and Specifications
13.8.3 Tonghua Dongbao Pharmaceutical GLP-1 Weight Loss Drug Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 Tonghua Dongbao Pharmaceutical Main Business Overview
13.8.5 Tonghua Dongbao Pharmaceutical Latest Developments
13.9 Huadong Medicine
13.9.1 Huadong Medicine Company Information
13.9.2 Huadong Medicine GLP-1 Weight Loss Drug Product Portfolios and Specifications
13.9.3 Huadong Medicine GLP-1 Weight Loss Drug Sales, Revenue, Price and Gross Margin (2021-2026)
13.9.4 Huadong Medicine Main Business Overview
13.9.5 Huadong Medicine Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. GLP-1 Weight Loss Drug Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. GLP-1 Weight Loss Drug Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Injection
Table 4. Major Players of Oral
Table 5. Global GLP-1 Weight Loss Drug Sales by Type (2021-2026) & (K Units)
Table 6. Global GLP-1 Weight Loss Drug Sales Market Share by Type (2021-2026)
Table 7. Global GLP-1 Weight Loss Drug Revenue by Type (2021-2026) & ($ million)
Table 8. Global GLP-1 Weight Loss Drug Revenue Market Share by Type (2021-2026)
Table 9. Global GLP-1 Weight Loss Drug Sale Price by Type (2021-2026) & (US$/Unit)
Table 10. Global GLP-1 Weight Loss Drug Sale by Application (2021-2026) & (K Units)
Table 11. Global GLP-1 Weight Loss Drug Sale Market Share by Application (2021-2026)
Table 12. Global GLP-1 Weight Loss Drug Revenue by Application (2021-2026) & ($ million)
Table 13. Global GLP-1 Weight Loss Drug Revenue Market Share by Application (2021-2026)
Table 14. Global GLP-1 Weight Loss Drug Sale Price by Application (2021-2026) & (US$/Unit)
Table 15. Global GLP-1 Weight Loss Drug Sales by Company (2021-2026) & (K Units)
Table 16. Global GLP-1 Weight Loss Drug Sales Market Share by Company (2021-2026)
Table 17. Global GLP-1 Weight Loss Drug Revenue by Company (2021-2026) & ($ millions)
Table 18. Global GLP-1 Weight Loss Drug Revenue Market Share by Company (2021-2026)
Table 19. Global GLP-1 Weight Loss Drug Sale Price by Company (2021-2026) & (US$/Unit)
Table 20. Key Manufacturers GLP-1 Weight Loss Drug Producing Area Distribution and Sales Area
Table 21. Players GLP-1 Weight Loss Drug Products Offered
Table 22. GLP-1 Weight Loss Drug Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global GLP-1 Weight Loss Drug Sales by Geographic Region (2021-2026) & (K Units)
Table 26. Global GLP-1 Weight Loss Drug Sales Market Share Geographic Region (2021-2026)
Table 27. Global GLP-1 Weight Loss Drug Revenue by Geographic Region (2021-2026) & ($ millions)
Table 28. Global GLP-1 Weight Loss Drug Revenue Market Share by Geographic Region (2021-2026)
Table 29. Global GLP-1 Weight Loss Drug Sales by Country/Region (2021-2026) & (K Units)
Table 30. Global GLP-1 Weight Loss Drug Sales Market Share by Country/Region (2021-2026)
Table 31. Global GLP-1 Weight Loss Drug Revenue by Country/Region (2021-2026) & ($ millions)
Table 32. Global GLP-1 Weight Loss Drug Revenue Market Share by Country/Region (2021-2026)
Table 33. Americas GLP-1 Weight Loss Drug Sales by Country (2021-2026) & (K Units)
Table 34. Americas GLP-1 Weight Loss Drug Sales Market Share by Country (2021-2026)
Table 35. Americas GLP-1 Weight Loss Drug Revenue by Country (2021-2026) & ($ millions)
Table 36. Americas GLP-1 Weight Loss Drug Sales by Type (2021-2026) & (K Units)
Table 37. Americas GLP-1 Weight Loss Drug Sales by Application (2021-2026) & (K Units)
Table 38. APAC GLP-1 Weight Loss Drug Sales by Region (2021-2026) & (K Units)
Table 39. APAC GLP-1 Weight Loss Drug Sales Market Share by Region (2021-2026)
Table 40. APAC GLP-1 Weight Loss Drug Revenue by Region (2021-2026) & ($ millions)
Table 41. APAC GLP-1 Weight Loss Drug Sales by Type (2021-2026) & (K Units)
Table 42. APAC GLP-1 Weight Loss Drug Sales by Application (2021-2026) & (K Units)
Table 43. Europe GLP-1 Weight Loss Drug Sales by Country (2021-2026) & (K Units)
Table 44. Europe GLP-1 Weight Loss Drug Revenue by Country (2021-2026) & ($ millions)
Table 45. Europe GLP-1 Weight Loss Drug Sales by Type (2021-2026) & (K Units)
Table 46. Europe GLP-1 Weight Loss Drug Sales by Application (2021-2026) & (K Units)
Table 47. Middle East & Africa GLP-1 Weight Loss Drug Sales by Country (2021-2026) & (K Units)
Table 48. Middle East & Africa GLP-1 Weight Loss Drug Revenue Market Share by Country (2021-2026)
Table 49. Middle East & Africa GLP-1 Weight Loss Drug Sales by Type (2021-2026) & (K Units)
Table 50. Middle East & Africa GLP-1 Weight Loss Drug Sales by Application (2021-2026) & (K Units)
Table 51. Key Market Drivers & Growth Opportunities of GLP-1 Weight Loss Drug
Table 52. Key Market Challenges & Risks of GLP-1 Weight Loss Drug
Table 53. Key Industry Trends of GLP-1 Weight Loss Drug
Table 54. GLP-1 Weight Loss Drug Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. GLP-1 Weight Loss Drug Distributors List
Table 57. GLP-1 Weight Loss Drug Customer List
Table 58. Global GLP-1 Weight Loss Drug Sales Forecast by Region (2027-2032) & (K Units)
Table 59. Global GLP-1 Weight Loss Drug Revenue Forecast by Region (2027-2032) & ($ millions)
Table 60. Americas GLP-1 Weight Loss Drug Sales Forecast by Country (2027-2032) & (K Units)
Table 61. Americas GLP-1 Weight Loss Drug Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 62. APAC GLP-1 Weight Loss Drug Sales Forecast by Region (2027-2032) & (K Units)
Table 63. APAC GLP-1 Weight Loss Drug Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 64. Europe GLP-1 Weight Loss Drug Sales Forecast by Country (2027-2032) & (K Units)
Table 65. Europe GLP-1 Weight Loss Drug Revenue Forecast by Country (2027-2032) & ($ millions)
Table 66. Middle East & Africa GLP-1 Weight Loss Drug Sales Forecast by Country (2027-2032) & (K Units)
Table 67. Middle East & Africa GLP-1 Weight Loss Drug Revenue Forecast by Country (2027-2032) & ($ millions)
Table 68. Global GLP-1 Weight Loss Drug Sales Forecast by Type (2027-2032) & (K Units)
Table 69. Global GLP-1 Weight Loss Drug Revenue Forecast by Type (2027-2032) & ($ millions)
Table 70. Global GLP-1 Weight Loss Drug Sales Forecast by Application (2027-2032) & (K Units)
Table 71. Global GLP-1 Weight Loss Drug Revenue Forecast by Application (2027-2032) & ($ millions)
Table 72. Novo Nordisk Basic Information, GLP-1 Weight Loss Drug Manufacturing Base, Sales Area and Its Competitors
Table 73. Novo Nordisk GLP-1 Weight Loss Drug Product Portfolios and Specifications
Table 74. Novo Nordisk GLP-1 Weight Loss Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 75. Novo Nordisk Main Business
Table 76. Novo Nordisk Latest Developments
Table 77. AstraZeneca Basic Information, GLP-1 Weight Loss Drug Manufacturing Base, Sales Area and Its Competitors
Table 78. AstraZeneca GLP-1 Weight Loss Drug Product Portfolios and Specifications
Table 79. AstraZeneca GLP-1 Weight Loss Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 80. AstraZeneca Main Business
Table 81. AstraZeneca Latest Developments
Table 82. Eli Lilly Basic Information, GLP-1 Weight Loss Drug Manufacturing Base, Sales Area and Its Competitors
Table 83. Eli Lilly GLP-1 Weight Loss Drug Product Portfolios and Specifications
Table 84. Eli Lilly GLP-1 Weight Loss Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 85. Eli Lilly Main Business
Table 86. Eli Lilly Latest Developments
Table 87. Sanofi Basic Information, GLP-1 Weight Loss Drug Manufacturing Base, Sales Area and Its Competitors
Table 88. Sanofi GLP-1 Weight Loss Drug Product Portfolios and Specifications
Table 89. Sanofi GLP-1 Weight Loss Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 90. Sanofi Main Business
Table 91. Sanofi Latest Developments
Table 92. BENEMAE Basic Information, GLP-1 Weight Loss Drug Manufacturing Base, Sales Area and Its Competitors
Table 93. BENEMAE GLP-1 Weight Loss Drug Product Portfolios and Specifications
Table 94. BENEMAE GLP-1 Weight Loss Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 95. BENEMAE Main Business
Table 96. BENEMAE Latest Developments
Table 97. HANSOH PHARMLA Basic Information, GLP-1 Weight Loss Drug Manufacturing Base, Sales Area and Its Competitors
Table 98. HANSOH PHARMLA GLP-1 Weight Loss Drug Product Portfolios and Specifications
Table 99. HANSOH PHARMLA GLP-1 Weight Loss Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 100. HANSOH PHARMLA Main Business
Table 101. HANSOH PHARMLA Latest Developments
Table 102. CHIATAI TIANQING Basic Information, GLP-1 Weight Loss Drug Manufacturing Base, Sales Area and Its Competitors
Table 103. CHIATAI TIANQING GLP-1 Weight Loss Drug Product Portfolios and Specifications
Table 104. CHIATAI TIANQING GLP-1 Weight Loss Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 105. CHIATAI TIANQING Main Business
Table 106. CHIATAI TIANQING Latest Developments
Table 107. Tonghua Dongbao Pharmaceutical Basic Information, GLP-1 Weight Loss Drug Manufacturing Base, Sales Area and Its Competitors
Table 108. Tonghua Dongbao Pharmaceutical GLP-1 Weight Loss Drug Product Portfolios and Specifications
Table 109. Tonghua Dongbao Pharmaceutical GLP-1 Weight Loss Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 110. Tonghua Dongbao Pharmaceutical Main Business
Table 111. Tonghua Dongbao Pharmaceutical Latest Developments
Table 112. Huadong Medicine Basic Information, GLP-1 Weight Loss Drug Manufacturing Base, Sales Area and Its Competitors
Table 113. Huadong Medicine GLP-1 Weight Loss Drug Product Portfolios and Specifications
Table 114. Huadong Medicine GLP-1 Weight Loss Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 115. Huadong Medicine Main Business
Table 116. Huadong Medicine Latest Developments
Table 1. GLP-1 Weight Loss Drug Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. GLP-1 Weight Loss Drug Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Injection
Table 4. Major Players of Oral
Table 5. Global GLP-1 Weight Loss Drug Sales by Type (2021-2026) & (K Units)
Table 6. Global GLP-1 Weight Loss Drug Sales Market Share by Type (2021-2026)
Table 7. Global GLP-1 Weight Loss Drug Revenue by Type (2021-2026) & ($ million)
Table 8. Global GLP-1 Weight Loss Drug Revenue Market Share by Type (2021-2026)
Table 9. Global GLP-1 Weight Loss Drug Sale Price by Type (2021-2026) & (US$/Unit)
Table 10. Global GLP-1 Weight Loss Drug Sale by Application (2021-2026) & (K Units)
Table 11. Global GLP-1 Weight Loss Drug Sale Market Share by Application (2021-2026)
Table 12. Global GLP-1 Weight Loss Drug Revenue by Application (2021-2026) & ($ million)
Table 13. Global GLP-1 Weight Loss Drug Revenue Market Share by Application (2021-2026)
Table 14. Global GLP-1 Weight Loss Drug Sale Price by Application (2021-2026) & (US$/Unit)
Table 15. Global GLP-1 Weight Loss Drug Sales by Company (2021-2026) & (K Units)
Table 16. Global GLP-1 Weight Loss Drug Sales Market Share by Company (2021-2026)
Table 17. Global GLP-1 Weight Loss Drug Revenue by Company (2021-2026) & ($ millions)
Table 18. Global GLP-1 Weight Loss Drug Revenue Market Share by Company (2021-2026)
Table 19. Global GLP-1 Weight Loss Drug Sale Price by Company (2021-2026) & (US$/Unit)
Table 20. Key Manufacturers GLP-1 Weight Loss Drug Producing Area Distribution and Sales Area
Table 21. Players GLP-1 Weight Loss Drug Products Offered
Table 22. GLP-1 Weight Loss Drug Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global GLP-1 Weight Loss Drug Sales by Geographic Region (2021-2026) & (K Units)
Table 26. Global GLP-1 Weight Loss Drug Sales Market Share Geographic Region (2021-2026)
Table 27. Global GLP-1 Weight Loss Drug Revenue by Geographic Region (2021-2026) & ($ millions)
Table 28. Global GLP-1 Weight Loss Drug Revenue Market Share by Geographic Region (2021-2026)
Table 29. Global GLP-1 Weight Loss Drug Sales by Country/Region (2021-2026) & (K Units)
Table 30. Global GLP-1 Weight Loss Drug Sales Market Share by Country/Region (2021-2026)
Table 31. Global GLP-1 Weight Loss Drug Revenue by Country/Region (2021-2026) & ($ millions)
Table 32. Global GLP-1 Weight Loss Drug Revenue Market Share by Country/Region (2021-2026)
Table 33. Americas GLP-1 Weight Loss Drug Sales by Country (2021-2026) & (K Units)
Table 34. Americas GLP-1 Weight Loss Drug Sales Market Share by Country (2021-2026)
Table 35. Americas GLP-1 Weight Loss Drug Revenue by Country (2021-2026) & ($ millions)
Table 36. Americas GLP-1 Weight Loss Drug Sales by Type (2021-2026) & (K Units)
Table 37. Americas GLP-1 Weight Loss Drug Sales by Application (2021-2026) & (K Units)
Table 38. APAC GLP-1 Weight Loss Drug Sales by Region (2021-2026) & (K Units)
Table 39. APAC GLP-1 Weight Loss Drug Sales Market Share by Region (2021-2026)
Table 40. APAC GLP-1 Weight Loss Drug Revenue by Region (2021-2026) & ($ millions)
Table 41. APAC GLP-1 Weight Loss Drug Sales by Type (2021-2026) & (K Units)
Table 42. APAC GLP-1 Weight Loss Drug Sales by Application (2021-2026) & (K Units)
Table 43. Europe GLP-1 Weight Loss Drug Sales by Country (2021-2026) & (K Units)
Table 44. Europe GLP-1 Weight Loss Drug Revenue by Country (2021-2026) & ($ millions)
Table 45. Europe GLP-1 Weight Loss Drug Sales by Type (2021-2026) & (K Units)
Table 46. Europe GLP-1 Weight Loss Drug Sales by Application (2021-2026) & (K Units)
Table 47. Middle East & Africa GLP-1 Weight Loss Drug Sales by Country (2021-2026) & (K Units)
Table 48. Middle East & Africa GLP-1 Weight Loss Drug Revenue Market Share by Country (2021-2026)
Table 49. Middle East & Africa GLP-1 Weight Loss Drug Sales by Type (2021-2026) & (K Units)
Table 50. Middle East & Africa GLP-1 Weight Loss Drug Sales by Application (2021-2026) & (K Units)
Table 51. Key Market Drivers & Growth Opportunities of GLP-1 Weight Loss Drug
Table 52. Key Market Challenges & Risks of GLP-1 Weight Loss Drug
Table 53. Key Industry Trends of GLP-1 Weight Loss Drug
Table 54. GLP-1 Weight Loss Drug Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. GLP-1 Weight Loss Drug Distributors List
Table 57. GLP-1 Weight Loss Drug Customer List
Table 58. Global GLP-1 Weight Loss Drug Sales Forecast by Region (2027-2032) & (K Units)
Table 59. Global GLP-1 Weight Loss Drug Revenue Forecast by Region (2027-2032) & ($ millions)
Table 60. Americas GLP-1 Weight Loss Drug Sales Forecast by Country (2027-2032) & (K Units)
Table 61. Americas GLP-1 Weight Loss Drug Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 62. APAC GLP-1 Weight Loss Drug Sales Forecast by Region (2027-2032) & (K Units)
Table 63. APAC GLP-1 Weight Loss Drug Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 64. Europe GLP-1 Weight Loss Drug Sales Forecast by Country (2027-2032) & (K Units)
Table 65. Europe GLP-1 Weight Loss Drug Revenue Forecast by Country (2027-2032) & ($ millions)
Table 66. Middle East & Africa GLP-1 Weight Loss Drug Sales Forecast by Country (2027-2032) & (K Units)
Table 67. Middle East & Africa GLP-1 Weight Loss Drug Revenue Forecast by Country (2027-2032) & ($ millions)
Table 68. Global GLP-1 Weight Loss Drug Sales Forecast by Type (2027-2032) & (K Units)
Table 69. Global GLP-1 Weight Loss Drug Revenue Forecast by Type (2027-2032) & ($ millions)
Table 70. Global GLP-1 Weight Loss Drug Sales Forecast by Application (2027-2032) & (K Units)
Table 71. Global GLP-1 Weight Loss Drug Revenue Forecast by Application (2027-2032) & ($ millions)
Table 72. Novo Nordisk Basic Information, GLP-1 Weight Loss Drug Manufacturing Base, Sales Area and Its Competitors
Table 73. Novo Nordisk GLP-1 Weight Loss Drug Product Portfolios and Specifications
Table 74. Novo Nordisk GLP-1 Weight Loss Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 75. Novo Nordisk Main Business
Table 76. Novo Nordisk Latest Developments
Table 77. AstraZeneca Basic Information, GLP-1 Weight Loss Drug Manufacturing Base, Sales Area and Its Competitors
Table 78. AstraZeneca GLP-1 Weight Loss Drug Product Portfolios and Specifications
Table 79. AstraZeneca GLP-1 Weight Loss Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 80. AstraZeneca Main Business
Table 81. AstraZeneca Latest Developments
Table 82. Eli Lilly Basic Information, GLP-1 Weight Loss Drug Manufacturing Base, Sales Area and Its Competitors
Table 83. Eli Lilly GLP-1 Weight Loss Drug Product Portfolios and Specifications
Table 84. Eli Lilly GLP-1 Weight Loss Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 85. Eli Lilly Main Business
Table 86. Eli Lilly Latest Developments
Table 87. Sanofi Basic Information, GLP-1 Weight Loss Drug Manufacturing Base, Sales Area and Its Competitors
Table 88. Sanofi GLP-1 Weight Loss Drug Product Portfolios and Specifications
Table 89. Sanofi GLP-1 Weight Loss Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 90. Sanofi Main Business
Table 91. Sanofi Latest Developments
Table 92. BENEMAE Basic Information, GLP-1 Weight Loss Drug Manufacturing Base, Sales Area and Its Competitors
Table 93. BENEMAE GLP-1 Weight Loss Drug Product Portfolios and Specifications
Table 94. BENEMAE GLP-1 Weight Loss Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 95. BENEMAE Main Business
Table 96. BENEMAE Latest Developments
Table 97. HANSOH PHARMLA Basic Information, GLP-1 Weight Loss Drug Manufacturing Base, Sales Area and Its Competitors
Table 98. HANSOH PHARMLA GLP-1 Weight Loss Drug Product Portfolios and Specifications
Table 99. HANSOH PHARMLA GLP-1 Weight Loss Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 100. HANSOH PHARMLA Main Business
Table 101. HANSOH PHARMLA Latest Developments
Table 102. CHIATAI TIANQING Basic Information, GLP-1 Weight Loss Drug Manufacturing Base, Sales Area and Its Competitors
Table 103. CHIATAI TIANQING GLP-1 Weight Loss Drug Product Portfolios and Specifications
Table 104. CHIATAI TIANQING GLP-1 Weight Loss Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 105. CHIATAI TIANQING Main Business
Table 106. CHIATAI TIANQING Latest Developments
Table 107. Tonghua Dongbao Pharmaceutical Basic Information, GLP-1 Weight Loss Drug Manufacturing Base, Sales Area and Its Competitors
Table 108. Tonghua Dongbao Pharmaceutical GLP-1 Weight Loss Drug Product Portfolios and Specifications
Table 109. Tonghua Dongbao Pharmaceutical GLP-1 Weight Loss Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 110. Tonghua Dongbao Pharmaceutical Main Business
Table 111. Tonghua Dongbao Pharmaceutical Latest Developments
Table 112. Huadong Medicine Basic Information, GLP-1 Weight Loss Drug Manufacturing Base, Sales Area and Its Competitors
Table 113. Huadong Medicine GLP-1 Weight Loss Drug Product Portfolios and Specifications
Table 114. Huadong Medicine GLP-1 Weight Loss Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 115. Huadong Medicine Main Business
Table 116. Huadong Medicine Latest Developments
LIST OF FIGURES
Figure 1. Picture of GLP-1 Weight Loss Drug
Figure 2. GLP-1 Weight Loss Drug Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global GLP-1 Weight Loss Drug Sales Growth Rate 2021-2032 (K Units)
Figure 7. Global GLP-1 Weight Loss Drug Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. GLP-1 Weight Loss Drug Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. GLP-1 Weight Loss Drug Sales Market Share by Country/Region (2025)
Figure 10. GLP-1 Weight Loss Drug Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Injection
Figure 12. Product Picture of Oral
Figure 13. Global GLP-1 Weight Loss Drug Sales Market Share by Type in 2026
Figure 14. Global GLP-1 Weight Loss Drug Revenue Market Share by Type (2021-2026)
Figure 15. GLP-1 Weight Loss Drug Consumed in Online Pharmacy
Figure 16. Global GLP-1 Weight Loss Drug Market: Online Pharmacy (2021-2026) & (K Units)
Figure 17. GLP-1 Weight Loss Drug Consumed in Offline Pharmacy
Figure 18. Global GLP-1 Weight Loss Drug Market: Offline Pharmacy (2021-2026) & (K Units)
Figure 19. Global GLP-1 Weight Loss Drug Sale Market Share by Application (2025)
Figure 20. Global GLP-1 Weight Loss Drug Revenue Market Share by Application in 2026
Figure 21. GLP-1 Weight Loss Drug Sales by Company in 2026 (K Units)
Figure 22. Global GLP-1 Weight Loss Drug Sales Market Share by Company in 2026
Figure 23. GLP-1 Weight Loss Drug Revenue by Company in 2026 ($ millions)
Figure 24. Global GLP-1 Weight Loss Drug Revenue Market Share by Company in 2026
Figure 25. Global GLP-1 Weight Loss Drug Sales Market Share by Geographic Region (2021-2026)
Figure 26. Global GLP-1 Weight Loss Drug Revenue Market Share by Geographic Region in 2026
Figure 27. Americas GLP-1 Weight Loss Drug Sales 2021-2026 (K Units)
Figure 28. Americas GLP-1 Weight Loss Drug Revenue 2021-2026 ($ millions)
Figure 29. APAC GLP-1 Weight Loss Drug Sales 2021-2026 (K Units)
Figure 30. APAC GLP-1 Weight Loss Drug Revenue 2021-2026 ($ millions)
Figure 31. Europe GLP-1 Weight Loss Drug Sales 2021-2026 (K Units)
Figure 32. Europe GLP-1 Weight Loss Drug Revenue 2021-2026 ($ millions)
Figure 33. Middle East & Africa GLP-1 Weight Loss Drug Sales 2021-2026 (K Units)
Figure 34. Middle East & Africa GLP-1 Weight Loss Drug Revenue 2021-2026 ($ millions)
Figure 35. Americas GLP-1 Weight Loss Drug Sales Market Share by Country in 2026
Figure 36. Americas GLP-1 Weight Loss Drug Revenue Market Share by Country (2021-2026)
Figure 37. Americas GLP-1 Weight Loss Drug Sales Market Share by Type (2021-2026)
Figure 38. Americas GLP-1 Weight Loss Drug Sales Market Share by Application (2021-2026)
Figure 39. United States GLP-1 Weight Loss Drug Revenue Growth 2021-2026 ($ millions)
Figure 40. Canada GLP-1 Weight Loss Drug Revenue Growth 2021-2026 ($ millions)
Figure 41. Mexico GLP-1 Weight Loss Drug Revenue Growth 2021-2026 ($ millions)
Figure 42. Brazil GLP-1 Weight Loss Drug Revenue Growth 2021-2026 ($ millions)
Figure 43. APAC GLP-1 Weight Loss Drug Sales Market Share by Region in 2026
Figure 44. APAC GLP-1 Weight Loss Drug Revenue Market Share by Region (2021-2026)
Figure 45. APAC GLP-1 Weight Loss Drug Sales Market Share by Type (2021-2026)
Figure 46. APAC GLP-1 Weight Loss Drug Sales Market Share by Application (2021-2026)
Figure 47. China GLP-1 Weight Loss Drug Revenue Growth 2021-2026 ($ millions)
Figure 48. Japan GLP-1 Weight Loss Drug Revenue Growth 2021-2026 ($ millions)
Figure 49. South Korea GLP-1 Weight Loss Drug Revenue Growth 2021-2026 ($ millions)
Figure 50. Southeast Asia GLP-1 Weight Loss Drug Revenue Growth 2021-2026 ($ millions)
Figure 51. India GLP-1 Weight Loss Drug Revenue Growth 2021-2026 ($ millions)
Figure 52. Australia GLP-1 Weight Loss Drug Revenue Growth 2021-2026 ($ millions)
Figure 53. China Taiwan GLP-1 Weight Loss Drug Revenue Growth 2021-2026 ($ millions)
Figure 54. Europe GLP-1 Weight Loss Drug Sales Market Share by Country in 2026
Figure 55. Europe GLP-1 Weight Loss Drug Revenue Market Share by Country (2021-2026)
Figure 56. Europe GLP-1 Weight Loss Drug Sales Market Share by Type (2021-2026)
Figure 57. Europe GLP-1 Weight Loss Drug Sales Market Share by Application (2021-2026)
Figure 58. Germany GLP-1 Weight Loss Drug Revenue Growth 2021-2026 ($ millions)
Figure 59. France GLP-1 Weight Loss Drug Revenue Growth 2021-2026 ($ millions)
Figure 60. UK GLP-1 Weight Loss Drug Revenue Growth 2021-2026 ($ millions)
Figure 61. Italy GLP-1 Weight Loss Drug Revenue Growth 2021-2026 ($ millions)
Figure 62. Russia GLP-1 Weight Loss Drug Revenue Growth 2021-2026 ($ millions)
Figure 63. Middle East & Africa GLP-1 Weight Loss Drug Sales Market Share by Country (2021-2026)
Figure 64. Middle East & Africa GLP-1 Weight Loss Drug Sales Market Share by Type (2021-2026)
Figure 65. Middle East & Africa GLP-1 Weight Loss Drug Sales Market Share by Application (2021-2026)
Figure 66. Egypt GLP-1 Weight Loss Drug Revenue Growth 2021-2026 ($ millions)
Figure 67. South Africa GLP-1 Weight Loss Drug Revenue Growth 2021-2026 ($ millions)
Figure 68. Israel GLP-1 Weight Loss Drug Revenue Growth 2021-2026 ($ millions)
Figure 69. Turkey GLP-1 Weight Loss Drug Revenue Growth 2021-2026 ($ millions)
Figure 70. GCC Countries GLP-1 Weight Loss Drug Revenue Growth 2021-2026 ($ millions)
Figure 71. Manufacturing Cost Structure Analysis of GLP-1 Weight Loss Drug in 2026
Figure 72. Manufacturing Process Analysis of GLP-1 Weight Loss Drug
Figure 73. Industry Chain Structure of GLP-1 Weight Loss Drug
Figure 74. Channels of Distribution
Figure 75. Global GLP-1 Weight Loss Drug Sales Market Forecast by Region (2027-2032)
Figure 76. Global GLP-1 Weight Loss Drug Revenue Market Share Forecast by Region (2027-2032)
Figure 77. Global GLP-1 Weight Loss Drug Sales Market Share Forecast by Type (2027-2032)
Figure 78. Global GLP-1 Weight Loss Drug Revenue Market Share Forecast by Type (2027-2032)
Figure 79. Global GLP-1 Weight Loss Drug Sales Market Share Forecast by Application (2027-2032)
Figure 80. Global GLP-1 Weight Loss Drug Revenue Market Share Forecast by Application (2027-2032)
Figure 1. Picture of GLP-1 Weight Loss Drug
Figure 2. GLP-1 Weight Loss Drug Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global GLP-1 Weight Loss Drug Sales Growth Rate 2021-2032 (K Units)
Figure 7. Global GLP-1 Weight Loss Drug Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. GLP-1 Weight Loss Drug Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. GLP-1 Weight Loss Drug Sales Market Share by Country/Region (2025)
Figure 10. GLP-1 Weight Loss Drug Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Injection
Figure 12. Product Picture of Oral
Figure 13. Global GLP-1 Weight Loss Drug Sales Market Share by Type in 2026
Figure 14. Global GLP-1 Weight Loss Drug Revenue Market Share by Type (2021-2026)
Figure 15. GLP-1 Weight Loss Drug Consumed in Online Pharmacy
Figure 16. Global GLP-1 Weight Loss Drug Market: Online Pharmacy (2021-2026) & (K Units)
Figure 17. GLP-1 Weight Loss Drug Consumed in Offline Pharmacy
Figure 18. Global GLP-1 Weight Loss Drug Market: Offline Pharmacy (2021-2026) & (K Units)
Figure 19. Global GLP-1 Weight Loss Drug Sale Market Share by Application (2025)
Figure 20. Global GLP-1 Weight Loss Drug Revenue Market Share by Application in 2026
Figure 21. GLP-1 Weight Loss Drug Sales by Company in 2026 (K Units)
Figure 22. Global GLP-1 Weight Loss Drug Sales Market Share by Company in 2026
Figure 23. GLP-1 Weight Loss Drug Revenue by Company in 2026 ($ millions)
Figure 24. Global GLP-1 Weight Loss Drug Revenue Market Share by Company in 2026
Figure 25. Global GLP-1 Weight Loss Drug Sales Market Share by Geographic Region (2021-2026)
Figure 26. Global GLP-1 Weight Loss Drug Revenue Market Share by Geographic Region in 2026
Figure 27. Americas GLP-1 Weight Loss Drug Sales 2021-2026 (K Units)
Figure 28. Americas GLP-1 Weight Loss Drug Revenue 2021-2026 ($ millions)
Figure 29. APAC GLP-1 Weight Loss Drug Sales 2021-2026 (K Units)
Figure 30. APAC GLP-1 Weight Loss Drug Revenue 2021-2026 ($ millions)
Figure 31. Europe GLP-1 Weight Loss Drug Sales 2021-2026 (K Units)
Figure 32. Europe GLP-1 Weight Loss Drug Revenue 2021-2026 ($ millions)
Figure 33. Middle East & Africa GLP-1 Weight Loss Drug Sales 2021-2026 (K Units)
Figure 34. Middle East & Africa GLP-1 Weight Loss Drug Revenue 2021-2026 ($ millions)
Figure 35. Americas GLP-1 Weight Loss Drug Sales Market Share by Country in 2026
Figure 36. Americas GLP-1 Weight Loss Drug Revenue Market Share by Country (2021-2026)
Figure 37. Americas GLP-1 Weight Loss Drug Sales Market Share by Type (2021-2026)
Figure 38. Americas GLP-1 Weight Loss Drug Sales Market Share by Application (2021-2026)
Figure 39. United States GLP-1 Weight Loss Drug Revenue Growth 2021-2026 ($ millions)
Figure 40. Canada GLP-1 Weight Loss Drug Revenue Growth 2021-2026 ($ millions)
Figure 41. Mexico GLP-1 Weight Loss Drug Revenue Growth 2021-2026 ($ millions)
Figure 42. Brazil GLP-1 Weight Loss Drug Revenue Growth 2021-2026 ($ millions)
Figure 43. APAC GLP-1 Weight Loss Drug Sales Market Share by Region in 2026
Figure 44. APAC GLP-1 Weight Loss Drug Revenue Market Share by Region (2021-2026)
Figure 45. APAC GLP-1 Weight Loss Drug Sales Market Share by Type (2021-2026)
Figure 46. APAC GLP-1 Weight Loss Drug Sales Market Share by Application (2021-2026)
Figure 47. China GLP-1 Weight Loss Drug Revenue Growth 2021-2026 ($ millions)
Figure 48. Japan GLP-1 Weight Loss Drug Revenue Growth 2021-2026 ($ millions)
Figure 49. South Korea GLP-1 Weight Loss Drug Revenue Growth 2021-2026 ($ millions)
Figure 50. Southeast Asia GLP-1 Weight Loss Drug Revenue Growth 2021-2026 ($ millions)
Figure 51. India GLP-1 Weight Loss Drug Revenue Growth 2021-2026 ($ millions)
Figure 52. Australia GLP-1 Weight Loss Drug Revenue Growth 2021-2026 ($ millions)
Figure 53. China Taiwan GLP-1 Weight Loss Drug Revenue Growth 2021-2026 ($ millions)
Figure 54. Europe GLP-1 Weight Loss Drug Sales Market Share by Country in 2026
Figure 55. Europe GLP-1 Weight Loss Drug Revenue Market Share by Country (2021-2026)
Figure 56. Europe GLP-1 Weight Loss Drug Sales Market Share by Type (2021-2026)
Figure 57. Europe GLP-1 Weight Loss Drug Sales Market Share by Application (2021-2026)
Figure 58. Germany GLP-1 Weight Loss Drug Revenue Growth 2021-2026 ($ millions)
Figure 59. France GLP-1 Weight Loss Drug Revenue Growth 2021-2026 ($ millions)
Figure 60. UK GLP-1 Weight Loss Drug Revenue Growth 2021-2026 ($ millions)
Figure 61. Italy GLP-1 Weight Loss Drug Revenue Growth 2021-2026 ($ millions)
Figure 62. Russia GLP-1 Weight Loss Drug Revenue Growth 2021-2026 ($ millions)
Figure 63. Middle East & Africa GLP-1 Weight Loss Drug Sales Market Share by Country (2021-2026)
Figure 64. Middle East & Africa GLP-1 Weight Loss Drug Sales Market Share by Type (2021-2026)
Figure 65. Middle East & Africa GLP-1 Weight Loss Drug Sales Market Share by Application (2021-2026)
Figure 66. Egypt GLP-1 Weight Loss Drug Revenue Growth 2021-2026 ($ millions)
Figure 67. South Africa GLP-1 Weight Loss Drug Revenue Growth 2021-2026 ($ millions)
Figure 68. Israel GLP-1 Weight Loss Drug Revenue Growth 2021-2026 ($ millions)
Figure 69. Turkey GLP-1 Weight Loss Drug Revenue Growth 2021-2026 ($ millions)
Figure 70. GCC Countries GLP-1 Weight Loss Drug Revenue Growth 2021-2026 ($ millions)
Figure 71. Manufacturing Cost Structure Analysis of GLP-1 Weight Loss Drug in 2026
Figure 72. Manufacturing Process Analysis of GLP-1 Weight Loss Drug
Figure 73. Industry Chain Structure of GLP-1 Weight Loss Drug
Figure 74. Channels of Distribution
Figure 75. Global GLP-1 Weight Loss Drug Sales Market Forecast by Region (2027-2032)
Figure 76. Global GLP-1 Weight Loss Drug Revenue Market Share Forecast by Region (2027-2032)
Figure 77. Global GLP-1 Weight Loss Drug Sales Market Share Forecast by Type (2027-2032)
Figure 78. Global GLP-1 Weight Loss Drug Revenue Market Share Forecast by Type (2027-2032)
Figure 79. Global GLP-1 Weight Loss Drug Sales Market Share Forecast by Application (2027-2032)
Figure 80. Global GLP-1 Weight Loss Drug Revenue Market Share Forecast by Application (2027-2032)
